AI Cancer Diagnostics Firm Ibex Granted FDA Breakthrough Device Designation
The designation is for the Ibex Galen platform, a solution that helps pathologists detect and grade cancer in biopsies.
June 09, 2021
Sponsored by the Asper Foundation and Reichman University
